Rejuve+ Focus & Clarity Mint Flavor
Natural health product licensed in Canada
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| 1,3,7-Triméthylxanthine Source : Caféine | 40 mg | Not calculated |
| Vitamine B12 Source : Méthylcobalamine | 333.33 Microgrammes | Not calculated |
| Magnésium Source : Citrate de magnésium | 30 mg | Not calculated |
Non-medicinal ingredients
Extrait de feuilles de stévia, Acide citrique, Cellulose microcristalline, Stéarate de magnésium, Saveur de menthe poivrée, Hydroxypropyl méthylcellulose, Laque d'aluminium jaune FD&C No. 5, Sucralose, Laque d'aluminium bleu FD&C n° 1, Dioxyde de titane, Saveur de menthe verte, Phosphate de calcium, dibasique, Maltodextrine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | 3 Comprimé | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Source of fungal polysaccharides with immunomodulating properties. Helps in bone development. Helps in energy metabolism/(and) tissue formation. Helps in the development and maintenance of bones/(and) teeth. Helps to form red blood cells. Helps to maintain/support healthy metabolism. Helps to maintain/support heart muscle function. Helps to maintain/support immune function/the immune system. Helps to maintain/support normal electrolyte balance. Helps to maintain/support normal muscle function, including the heart muscle. Helps to maintain/support the body's ability to metabolize nutrients. Helps to prevent vitamin B12 deficiency. Helps to prevent vitamin B6 deficiency. Helps with immune function/the immune system. Source of/Provides (an) electrolyte(s). Helps (temporarily) (to) promote alertness and wakefulness, and (to) enhance cognitive performance Helps (temporarily) (to) relieve/reduce fatigue/tiredness Helps (temporarily) (to) support/promote mental sharpness/alertness.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Product record
- Other names
- Focus chewable tablets, Nootropic Focus & Clarity, Recharge Chewables, Rejuve+ Focus Mint Flavor
- Licence holder
- OCHK International Trading Co.Ltd. DBA Rejuve Health Products
- NPN or DIN-HM
- 80132008
- Status
- Active licence
- Licence date
- 20 June 2024
- Revision date
- Not provided
- Form
- Comprimé, à croquer
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
Source
Official Health Canada record, licence 80132008
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Rejuve+ Focus & Clarity Mint Flavor”, https://compoatlas.com/en/supplements/canada/80132008-rejuve-focus-clarity-mint-flavor, updated 20 June 2024.